Evommune, Inc.
Clinical trials sponsored by Evommune, Inc., explained in plain language.
-
New drug shows promise for chronic hives in early trial
Symptom relief CompletedThis study tested a new drug called EVO756 in 30 adults with chronic inducible urticaria, a condition where things like scratching or cold trigger painful hives. The main goal was to see if the drug is safe and tolerable. Researchers also checked if it reduced the number of hives…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Symptom relief
Last updated May 26, 2026 12:07 UTC
-
New eczema drug shows promise in early trial
Symptom relief CompletedThis study tested an experimental drug, EVO301, in 71 adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if the drug safely reduces skin redness, thickness, and itch. Participants received either EVO301 or a placebo, and doctors measured changes in ski…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Symptom relief
Last updated May 26, 2026 10:35 UTC